• IMMUNIVATION: DISCOVER OUR APPROACH TO IMMUNE ACTIVATION

hp-people-3.png pink_scrubs.png Dr-Glasses.png NEKTAR_HERO_550x429_FRAME_8.png iStock_86712797_XXXLARGE-outline_LM.png NEKTAR_HERO_550x429_FRAME_7.png blue_shirt_masthead_man_v1_MAG.png NKT-hp-people-Michelle_v1_LM.png man-in-sweater_90824869_v1MAG.png iStock_68713947_XXLARGE-outiline_LM.png hp-people-3.png iStock_87627749_XXXLARGE-outline_LM.png NEKTAR_HERO_550x429_FRAME_11.png iStock-629599866_1.png NKT-hp-people-Mekhala_v1_LM.png NEKTAR_HERO_550x429_FRAME_13.png NEKTAR_HERO_550x429_FRAME_12.png NEKTAR_HERO_550x429_FRAME_14.png

Events

DEC 06

Conference Call for Analysts at ESMO-IO
Geneva, Switzerland
1:00 p.m. GMT (8:00 a.m. ET)

Conference ID: 7797059

Listen to Webcast

 

DISCOVER OUR APPROACH

Watch

home-video_new102220.png

Learn about the role of the interleukin-2 (IL-2) pathway in activating the immune system.

Watch

box-events.jpg

Explore the role of the interleukin-15 (IL-15) pathway in immune response.

Latest News

OUR PIPELINE

We are focused on creating novel therapies aimed at selectively modulating the immune system to advance the treatment of cancer, autoimmune disorders and chronic inflammatory conditions.

  • 9

    Million patients benefit from our medicines

    9
    9
    9

  • 12

    Approved products around the world

    12
    12
    12

  • 16

    Clinical development programs

    16
    16
    16

Join Our Team

Find out what it’s like to be part of a dynamic team full of diverse perspectives and unique ideas, brought together by expertise and a passion for making a difference for patients with unmet medical needs.

Read more